Published in Hematology Week, July 31st, 2006
Study 1: Fatty acid-binding protein aP2 genetic variant reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.
According to recent research published in the journal Proceedings of the National Academy of Sciences of the United States of America, "Obesity and the associated pathologies including dyslipidemia, insulin resistance, type 2 diabetes, and cardiovascular disease constitute a major threat to global human health. Yet, the genetic factors that differentially predispose individuals to this cluster of pathologies...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2006-07-31)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.